The global biomaterials market size was estimated at USD 237.03 billion in 2025 and is projected to be worth around USD 1,173.91 billion by 2035, growing at a CAGR of 17.35% from 2026 to 2035. The innovations in materials and tech-driven aspects are the major companions of the market. The natural products and processes are an acknowledgement of the market, promoting demand for bioresorbable implants.

Biomaterials Market Statical Scope

The biomaterials are synthetic and natural materials designed to fit into the biological systems, mainly to serve the medical space. These substances help cure, resolve or replace the organs and tissues. The natural substances should be compatible and safe to cooperate with living tissues. The power of the market lies in the clear purpose and biocompatibility. While the applications act as a source of revenue for the market.

The smart biomaterials and polymer-related biomaterials are attracting brilliant profit to the market. This drives valuable expansion in the healthcare sector as the growing geriatric population happens to be a popular customer for the market.

Biomaterials Market Share, By Region, 2025 (%)

• North America – The North America regional segment dominated the market by 39% of share, with the great dominance of metallic biomaterials in the regional market. The AI-unified self-healing materials and smart materials are driving advanced growth in the regional market.
• Europe - Europe leads by 25% of profit with the popular trends of eco-friendly biodegradable materials and nanotechnology. This forms a strong base for the regional market aligned to the EU's carbon-neutral transition.
• Asia-Pacific – The Asia-Pacific region covers 20% of the profit with the effective government investments. The rising demand for cardiovascular and orthopedic devices accelerates the production volume of the metallic and natural biomaterials.
• LAMEA – The LAMEA region acquires 16% of the share with the growing cases of chronic wounds, burn injuries and diabetes. This tends to elevate the demand for tissue engineering solutions while the local manufacturing of modern products is elevating growth in the regional market.

Biomaterials Market Share, By Product, 2025 (%)

• Metallic – The metallic product segment dominated the market by 41% of share due to modern manufacturing processes that highlight porous structure fabrication and customized implant designs. While the performance of titanium alloys and novel procedures sharpens the segmental market strength.
• Polymers – The polymers segment covers 21% of the share with the transitions in biodegradable polymers. The robust R&D in scaffold technology is forming the best-in-class tissue engineering advancement portfolio to promote the segmental market.
• Natural – The natural segment leads by 20% of share, with the rising wound healing alternatives accelerating demand for naturally processed solutions. The sustainability and plant-related innovations elevate the segment position in the market.
• Ceramics – The ceramics segment acquires 18% of share with the confidence of nanocomposites and bioactive ceramic scaffolds. The customization perk and biomimetic materials are accompanying the market term providing the best interpreted natural bone structures.

Biomaterials Market Share, By Application, 2025 (%)

• Orthopedics – The orthopedics segment dominated the market by 25% of the share, with a commendable blend of growth through the role of degradable magnesium-related alloys. The 3D printing is another growth aspect for the segmental market as the joint conditions are at peak.
• Cardiovascular – Cardiovascular held 20% of the share with its proficiency in the active biomaterials. The amalgamation of natural biomaterials, 3D printing and new materials is embarking the segment towards valuable growth with its power in functional materials.
• Dental – Dental segment held 13% of share with the popular role of regenerative dentistry. The digitization and integration are a perk to the segmental market, while intelligent materials align best to sharpen the tissue engineering spectrum.
• Opthalmology – The segment covers 12% of the share, with the popular trend of contact lenses. The active and intelligent materials are driving advancement and development in the segment. This highlights stimuli-responsive smart systems with the power of hydrogels.
• Wound Healing – The wound healing leads by 10% of share with the rising diabetes cases. The self-healing and antibacterial materials are the popular growth factor for the segment. The clinical space highlights transitions in materials and solutions for wound healing.
• Tissue Engineering – The tissue engineering segment leads by 8% of share as its effective involvement in organ regeneration and bone repair unlocks the potential value of the segmental market with specific modern fabrication procedures.
• Plastic Surgery – The segment rises by 7% with the elevating numbers of plastic surgery operations due to the rising competition in the film industry or any other burn/scar condition. The modern soft tissue fillers are driving innovative materials and promoting aesthetic procedures in the market.
• Neurology – The neurology held 5% of the share with the commendable merger of neuroscience and material science. The hydrogels and nanomedicine are supportive in the therapeutics, providing help to the extreme Parkinson's and Alzheimer's conditions.

Top Companies in the Biomaterials Market

• Medtronic
• Evonik Industries AG
• Carpenter Technology Corporation
• Berkeley Advanced Biomaterials
• Invibio Ltd.
• Zimmer Biomet Holdings, Inc.
• BASF SE
• Covalon Technologies Ltd.
• Stryker
• Johnson & Johnson
• Dentsply Sirona
• CoorsTek Inc.
• Corbion
• Regenity Biosciences

Segments Covered in the Report

By Product

• Metallic
• Natural
• Ceramics
• Polymers

By Application

• Cardiovascular
  • Sensors
  • Stents
  • Guidewires
  • Implantable Cardiac Defibrillators
  • Pacemakers
  • Vascular Grafts
  • Others
• Ophthalmology
  • Synthetic Corneas
  • Intraocular Lens
  • Contact Lens
  • Ocular Tissue Replacement
  • Others
• Dental
• Tissue Regeneration Materials
  • Dental Implants
  • Bone Grafts & Substitutes
  • Dental Membranes
  • Others
• Orthopedics
  • Joint Replacement biomaterials
  • Orthobiologics
  • Bioresorbable Tissue Fixation Products
  • Viscosupplementation
  • Spine Biomaterials
  • Others
• Wound Healing
  • Fracture Healing Device
  • Adhesion Barrier
  • Skin Substitutes
  • Internal Tissue Sealant
  • Surgical Hemostats
  • Others
• Tissue Engineering
• Plastic Surgery
  • Facial Wrinkle Treatment
  • Soft Tissue Fillers
  • Craniofacial Surgery
  • Bioengineered Skins
  • Peripheral Nerve Repair
  • Acellular Dermal Matrices
  • Others
• Neurology
  • Neural Stem Cell Encapsulation
  • Shunting Systems
  • Hydrogel Scaffold For CNS Repair
  • Cortical Neural Prosthetics
  • Others
• Others

By Regional

• North America
• U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Australia
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait